Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07188428 · ClinicalTrials.gov registry record
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
A clinical trial of Leukemia, Chronic Myeloid, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 2,298
- Enrollment target
- 1
- Study location
NCT07188428: Completed study of Leukemia, Chronic Myeloid, sponsored by Novartis Pharmaceuticals.
NCT07188428 is a study of Leukemia, Chronic Myeloid that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 2,298 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07188428, a study of Leukemia, Chronic Myeloid, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 2,298 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study was to evaluate the real-world treatment patterns, healthcare resource use and costs among patients newly diagnosed with CML who were treated with tyrosine kinase inhibitors (TKIs) in first- and second-line therapy.
Conditions Studied
Study Locations (1)
New Jersey
- Novartis - East Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,298 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2024-12-02 |
What the finished NCT07188428 record still lists
NCT07188428 is an observational study that tracks outcomes without assigning an intervention. Its 2,298 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Leukemia, Chronic Myeloid appearing as the primary indexed condition, and to 0 interventions.
NCT07188428 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07188428 about?
NCT07188428 is a clinical study titled "Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment". The aim of this study was to evaluate the real-world treatment patterns, healthcare resource use and costs among patients newly diagnosed with CML who were treated with tyrosine kinase inhibitors (TKIs) in first- and second-line therapy.
What is the current status of trial NCT07188428?
This trial is currently completed. The enrollment target is 2,298 participants. The study started on 2024-02-27. Estimated completion is 2024-12-02.
What conditions does trial NCT07188428 study?
This clinical trial studies the following conditions: Leukemia, Chronic Myeloid.
Who is sponsoring clinical trial NCT07188428?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07188428 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia, Chronic Myeloid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- NCT05732623 · 2,300 participants
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI